TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
KMDA

Kamada

Healthcare · Drug Manufacturers - Specialty & Generic

8.60$ -1.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

Kamada (KMDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 180 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement KMDA
Line item 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
13 15 15 36 56 73 71 72 70 77 103 114 127 133 104 129 143 161 180
10 15 16 30 40 50 44 56 54 56 71 73 77 86 73 83 87 91 104
3.2 0.1 -0.8 6.1 16 23 26 16 16 22 32 41 50 48 30 47 55 70 76
– 12 – 9.8 11 12 13 16 17 16 12 9.7 13 14 11 13 14 15 13
17 4.1 14 4.8 4.8 4.4 7.9 7.6 7.0 7.6 8.3 8.5 8.5 10 14 16 18 20 24
18 17 15 17 18 18 23 27 27 27 25 22 27 28 31 42 45 50 50
-16 -17 -16 -11 -2.3 4.2 3.7 -11 -11 -5.8 7.4 19 23 19 -0.7 4.5 10 20 26
0.4 4.6 4.0 5.0 3.8 3.4 3.2 3.0 0.9 0.1 0.1 0.3 0.3 0.3 0.3 0.9 1.3 0.7 0.9
-23 -12 -22 -15 -3.5 0.8 0.5 -13 -11 -5.0 7.2 20 23 19 -1.9 -2.3 8.4 13 23
8.1 -4.6 5.7 4.4 3.8 0.5 0.0 0.1 -0.2 1.7 0.3 -2.0 0.7 1.4 0.3 0.1 0.1 -1.1 3.3
-23 -12 -22 -15 -3.5 0.3 0.4 -13 -11 -6.7 6.9 22 22 17 -2.2 -2.3 8.3 14 20
-20 -15 -16 -9.4 2.7 7.2 8.1 -8.3 -7.1 -2.0 11 23 28 25 4.0 11 21 28 39

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?